(Q34401987)

1 August 2017

title

The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4. (English)

1 reference

1 August 2017

Le Mellédo JM

1

1 reference

1 August 2017

Arthur H

2

1 reference

1 August 2017

Dalton J

3

1 reference

1 August 2017

Woo C

4

1 reference

1 August 2017

Lipton N

5

1 reference

1 August 2017

Bellavance F

6

1 reference

1 August 2017

Koszycki D

7

1 reference

1 August 2017

Boulenger JP

8

1 reference

1 August 2017

Bradwejn J

9

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Journal of Psychosomatic Research

1 August 2017

published in

1 reference

1 August 2017

volume

51

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

513-520

1 reference

Coronary-prone behavior and coronary heart disease: a critical review. The review panel on coronary-prone behavior and coronary heart disease

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Type A behavior pattern and coronary disease risk. Update and critical evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Type A behavior and mortality from coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Prospective study of a self-report type A scale and risk of coronary heart disease: test of the MMPI-2 type A scale.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Type A behavior and survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

The MRFIT behavior pattern study. II. Type A behavior and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Refining the type A hypothesis: emergence of the hostility complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Effect of harassment and competition upon cardiovascular and plasma catecholamine responses in type A and type B individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

New markers for type A behavior: pupil size and platelet epinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Power spectral analysis of heart rate variability in Type As and Type Bs during mental workload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Sudden cardiac death: epidemiology, transient risk, and intervention assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Prospective study of phobic anxiety and risk of coronary heart disease in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Decreased heart rate variability in men with phobic anxiety (data from the Normative Aging Study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Medical diagnosis of type A behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Components of Type A, hostility, and anger-in: relationship to angiographic findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Components of hostility and the severity of coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Type A behavior pattern: facial behavior and speech components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Contribution of the vagus to the haemodynamic responses following intravenous boluses of isoprenaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Vagal activity is increased during intravenous isoprenaline infusion in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Correlation of type A behaviour with adrenergic receptor density: implications for coronary artery disease pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Denial specific to Friedman's pathogenic emotions in Jenkins Activity Survey Type A and angiography-referred males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Anxiety and coronary heart disease: a synthesis of epidemiological, psychological, and experimental evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Excess mortality in panic disorder. A comparison with primary unipolar depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Mortality among outpatients with anxiety disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

High cholesterol levels in patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Plasma lipid levels in patients with panic disorder or agoraphobia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

Potential for hostility and dimensions of anger.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Components of type A, hostility, and anger-in: further relationships to angiographic findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2801%2900190-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3999(01)00190-8

1 reference

1 August 2017

1 reference